The prognostic impact of the presence of mutations in CD34+ cells from CLL patients has been assessed for the first time in this study, showing that CLL patients harboring mutations in the hematopoietic progenitors showed worse prognosis. The gene discussed is CD34; the disease is B-cell chronic lymphocytic leukemia.